A rare case of myxedema coma with neuroleptic malignant syndrome (NMS)

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 5, 2015, Pages VD01-VD03

  Dixit, Siddharth ^a   Dutta, Manoj Kumar ^a   Namdeo, Mayank ^a  

^a BASE HOSPITAL   (India)

Author keywords

Atypical antipsychotics; Atypical neuroleptic malignant syndrome; Hypothyroid crisis; Primary hypothyroidism

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BROMOCRIPTINE; CEFTRIAXONE; CLONAZEPAM; DOPAMINE; FLUPHENAZINE DECANOATE; HALOPERIDOL; HYDROCORTISONE; LEVOTHYROXINE; NEUROLEPTIC AGENT; NORADRENALIN; OLANZAPINE; TRIHEXYPHENIDYL;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; FEMALE; FEVER; FLACCID PARALYSIS; GLASGOW COMA SCALE; HUMAN; HYPOTHERMIA; HYPOTHYROIDISM; HYPOXEMIA; LOADING DRUG DOSE; MUTISM; MYXEDEMA; NEUROLEPTIC MALIGNANT SYNDROME; PERICARDIAL EFFUSION; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA; TENDON REFLEX; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 84928990104     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/13008.5868     Document Type: Article

References (17)

1. Papi G, Corsello S, Pontecorvi A. Clinical Concepts on Thyroid Emergencies. Front Endocrinol. 2014;5:102. [Internet] [cited 6 January 2015]. Available from: http://dx.doi.org/10.3389/fendo.2014.00102.
2. Chopra MP, Prakash SS, Raguram R. The neuroleptic malignant syndrome: An Indian experience. Compr Psychiatry. 1999;40:19-23.
3. Galofre JC, Garcia Mayor RV. Densidad de incidentia dei mixedematoso. Endocrinologia. 1997;44:103-04.
4. Ahmad N, Panthari M, Gupta A, Chandra P, Nafees S. Prevalence of hypothyroidism among patients of Meerut, Uttar Pradesh: A hospital based study. Int J Med Sci Public Health. 2013;2:539-42.
5. Hehrmann R. Coma in myxedema-a rare complication of hypothyroidism. Possible iatrogenic factor should be taken into account. Fortschr Med. 1996;114(34):474-78.
6. Lanska D, Harsch HH. Hypothermic coma associated with thioradizine in a myxedematous patient. J Clin Psychiatry. 1984;45:188-89.
7. Church CO, Callen EC. Myxedema coma associated with combination aripiprazole and sertraline therapy. Ann Pharmacother. 2009;43:2113-16.
8. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137-45.
9. Picard LS, Lindsay S, Strawn J, Kaneria RM, Patel NC, Keck PE Jr. Atypical neuroleptic malignant syndrome: Diagnostic controversies and considerations. Pharmacotherapy. 2008;28:530-35.
10. Reeves RR, Torres RA, Liberto V, Hart RH. Atypical Neuroleptic Malignant Syndrome Associated With Olanzapine. Pharmacotherapy. 2002;22:641-44.
11. Yang CW, Lu C, Wu CC, Wen SC. Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state. Psychiatry and Clinical Neurosciences. 2010;64:79–87.
12. Moore AP, Macfarlane IA, Blumhardt LD. Neuroleptic malignant syndrome and hypothyroidism. J Neurol Neurosurg Psychiatry. 1990;53:517–18.
13. Kawajiri M, Ohyagi Y, Furuya H, Araki T, Inoue N, Esaki S, et al. A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam. Rinsho Shinkeigaku. 2002;42(2):136-39.
14. Hatch CD, Lund BC, Perry PC. Failed Challenge with Quetiapine after Neuroleptic Malignant Syndrome with Conventional Antipsychotics. Pharmacotherapy. 2001;21:1003-06.
15. Ananth J, Parmeswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65:464-70.
16. Taylor D, Paton C, Kapur S. Neuroleptic malignant syndrome. In: Taylor D, editor. The Maudsley Prescribing Guidelines in Psychiatry, 11th edn. Wiley Blackwell; 2012. pp.110-11.
17. Sussman N. Choosing an atypical antipsychotic. International Clinical Psychopharmacology. 2002;17:29-33.